FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891142141> ?p ?o ?g. }

• W2891142141 endingPage "866" @default.
• W2891142141 startingPage "858" @default.
• W2891142141 abstract "Objective The primary aim of this study was to develop and validate eye tracking−based measures for estimating autism spectrum disorder (ASD) risk and quantifying autism symptom levels. Method Eye tracking data were collected from youth during an initial evaluation visit, with administrators blinded to all clinical information. Consensus diagnoses were given by the multidisciplinary team. Participants viewed a 5-minute video that included 44 dynamic stimuli from 7 distinct paradigms while gaze was recorded. Gaze metrics were computed for temporally defined regions of interest. Autism risk and symptom indices aggregated gaze measures showing significant bivariate relationships with ASD diagnosis and Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) symptom severity levels in a training sample (75%, n = 150). Receiver operating characteristic curve analysis and nonparametric correlations were used to cross-validate findings in a test sample (25%; n = 51). Results Most children (n = 201, 92%) completed a valid eye tracking assessment (ages 1.6─17.6; 80% male; ASD n = 91, non-ASD n = 110). In the test subsample, the autism risk index had high accuracy for ASD diagnosis (area under the curve [AUC] = 0.86, 95% CI =0.75−0.95), whereas the autism symptom index was strongly associated with ADOS-2 total severity scores (r = 0.41, p < .001). Validity was not substantively attenuated after adjustment for language, nonverbal cognitive ability, or other psychopathology symptoms (r = 0.40−0.67, p > .001). Conclusion Eye tracking measures appear to be useful quantitative, objective measures of ASD risk and autism symptom levels. If independently replicated and scaled for clinical use, eye tracking−based measures could be used to inform clinical judgment regarding ASD identification and to track autism symptom levels. The primary aim of this study was to develop and validate eye tracking−based measures for estimating autism spectrum disorder (ASD) risk and quantifying autism symptom levels. Eye tracking data were collected from youth during an initial evaluation visit, with administrators blinded to all clinical information. Consensus diagnoses were given by the multidisciplinary team. Participants viewed a 5-minute video that included 44 dynamic stimuli from 7 distinct paradigms while gaze was recorded. Gaze metrics were computed for temporally defined regions of interest. Autism risk and symptom indices aggregated gaze measures showing significant bivariate relationships with ASD diagnosis and Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) symptom severity levels in a training sample (75%, n = 150). Receiver operating characteristic curve analysis and nonparametric correlations were used to cross-validate findings in a test sample (25%; n = 51). Most children (n = 201, 92%) completed a valid eye tracking assessment (ages 1.6─17.6; 80% male; ASD n = 91, non-ASD n = 110). In the test subsample, the autism risk index had high accuracy for ASD diagnosis (area under the curve [AUC] = 0.86, 95% CI =0.75−0.95), whereas the autism symptom index was strongly associated with ADOS-2 total severity scores (r = 0.41, p < .001). Validity was not substantively attenuated after adjustment for language, nonverbal cognitive ability, or other psychopathology symptoms (r = 0.40−0.67, p > .001). Eye tracking measures appear to be useful quantitative, objective measures of ASD risk and autism symptom levels. If independently replicated and scaled for clinical use, eye tracking−based measures could be used to inform clinical judgment regarding ASD identification and to track autism symptom levels." @default.
• W2891142141 created "2018-09-27" @default.
• W2891142141 creator A5017601490 @default.
• W2891142141 creator A5030193784 @default.
• W2891142141 creator A5031663349 @default.
• W2891142141 creator A5038322204 @default.
• W2891142141 creator A5048800466 @default.
• W2891142141 creator A5049203440 @default.
• W2891142141 creator A5070474755 @default.
• W2891142141 creator A5086029216 @default.
• W2891142141 date "2018-11-01" @default.
• W2891142141 modified "2023-09-30" @default.
• W2891142141 title "Development and Validation of Objective and Quantitative Eye Tracking−Based Measures of Autism Risk and Symptom Levels" @default.
• W2891142141 cites W1522674123 @default.
• W2891142141 cites W1773684352 @default.
• W2891142141 cites W1970391339 @default.
• W2891142141 cites W1972054739 @default.
• W2891142141 cites W1974652030 @default.
• W2891142141 cites W1993985496 @default.
• W2891142141 cites W2006617902 @default.
• W2891142141 cites W2007384358 @default.
• W2891142141 cites W2018553787 @default.
• W2891142141 cites W2022345199 @default.
• W2891142141 cites W2027481265 @default.
• W2891142141 cites W2030869286 @default.
• W2891142141 cites W2033675290 @default.
• W2891142141 cites W2044144140 @default.
• W2891142141 cites W2049567796 @default.
• W2891142141 cites W2051230880 @default.
• W2891142141 cites W2064094303 @default.
• W2891142141 cites W2078271269 @default.
• W2891142141 cites W2118347738 @default.
• W2891142141 cites W2119565940 @default.
• W2891142141 cites W2129516277 @default.
• W2891142141 cites W2150020283 @default.
• W2891142141 cites W2155846194 @default.
• W2891142141 cites W2162974025 @default.
• W2891142141 cites W2168561737 @default.
• W2891142141 cites W2269590076 @default.
• W2891142141 cites W2332016763 @default.
• W2891142141 cites W2336706572 @default.
• W2891142141 cites W236622834 @default.
• W2891142141 cites W2588003167 @default.
• W2891142141 cites W2612893437 @default.
• W2891142141 doi "https://doi.org/10.1016/j.jaac.2018.06.023" @default.
• W2891142141 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6220711" @default.
• W2891142141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30392627" @default.
• W2891142141 hasPublicationYear "2018" @default.
• W2891142141 type Work @default.
• W2891142141 sameAs 2891142141 @default.
• W2891142141 citedByCount "41" @default.
• W2891142141 countsByYear W28911421412019 @default.
• W2891142141 countsByYear W28911421412020 @default.
• W2891142141 countsByYear W28911421412021 @default.
• W2891142141 countsByYear W28911421412022 @default.
• W2891142141 countsByYear W28911421412023 @default.
• W2891142141 crossrefType "journal-article" @default.
• W2891142141 hasAuthorship W2891142141A5017601490 @default.
• W2891142141 hasAuthorship W2891142141A5030193784 @default.
• W2891142141 hasAuthorship W2891142141A5031663349 @default.
• W2891142141 hasAuthorship W2891142141A5038322204 @default.
• W2891142141 hasAuthorship W2891142141A5048800466 @default.
• W2891142141 hasAuthorship W2891142141A5049203440 @default.
• W2891142141 hasAuthorship W2891142141A5070474755 @default.
• W2891142141 hasAuthorship W2891142141A5086029216 @default.
• W2891142141 hasBestOaLocation W28911421412 @default.
• W2891142141 hasConcept C118552586 @default.
• W2891142141 hasConcept C126322002 @default.
• W2891142141 hasConcept C154945302 @default.
• W2891142141 hasConcept C15744967 @default.
• W2891142141 hasConcept C205778803 @default.
• W2891142141 hasConcept C2778538070 @default.
• W2891142141 hasConcept C2780055620 @default.
• W2891142141 hasConcept C41008148 @default.
• W2891142141 hasConcept C548259974 @default.
• W2891142141 hasConcept C56461940 @default.
• W2891142141 hasConcept C58471807 @default.
• W2891142141 hasConcept C70410870 @default.
• W2891142141 hasConcept C71924100 @default.
• W2891142141 hasConceptScore W2891142141C118552586 @default.
• W2891142141 hasConceptScore W2891142141C126322002 @default.
• W2891142141 hasConceptScore W2891142141C154945302 @default.
• W2891142141 hasConceptScore W2891142141C15744967 @default.
• W2891142141 hasConceptScore W2891142141C205778803 @default.
• W2891142141 hasConceptScore W2891142141C2778538070 @default.
• W2891142141 hasConceptScore W2891142141C2780055620 @default.
• W2891142141 hasConceptScore W2891142141C41008148 @default.
• W2891142141 hasConceptScore W2891142141C548259974 @default.
• W2891142141 hasConceptScore W2891142141C56461940 @default.
• W2891142141 hasConceptScore W2891142141C58471807 @default.
• W2891142141 hasConceptScore W2891142141C70410870 @default.
• W2891142141 hasConceptScore W2891142141C71924100 @default.
• W2891142141 hasFunder F4320332161 @default.
• W2891142141 hasFunder F4320337359 @default.
• W2891142141 hasFunder F4320337472 @default.
• W2891142141 hasIssue "11" @default.
• W2891142141 hasLocation W28911421411 @default.
• W2891142141 hasLocation W28911421412 @default.

• next